Stockscreener 앱 받기
49.47
1.24%
-0.62
시간 외 거래:
49.47
Royalty Pharma Plc 주식(RPRX)의 최신 뉴스
Royalty Pharma’s Q2 2026 Dividend Raises a Deeper Question About Its Capital Allocation Strategy (RPRX) - simplywall.st
Royalty Pharma (NASDAQ:RPRX) CFO Terrance Coyne Sells 34,791 Shares of Stock - MarketBeat
Royalty Pharma EVP & CFO Terrance Coyne disposes of $1.73m in stock - Investing.com India
Royalty Pharma Insider Sold Shares Worth $1,731,840, According to a Recent SEC Filing - marketscreener.com
Royalty Pharma (RPRX) CFO sells 34,791 shares under 10b5-1 plan - Stock Titan
Royalty Pharma Plc Hits New 52-Week High of $50.24 - Markets Mojo
Royalty Pharma Plc Experiences Revision in Its Stock Evaluation Amid Strong Performance - Markets Mojo
Royalty Pharma (RPRX) to Release Earnings on Wednesday - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Mitsubishi UFJ Trust & Banking Corp Increases Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma signs $500M co-development agreement with J&J - MSN
Affiliate sales disclosed for RPRX (NASDAQ: RPRX) in Form 144 filing - Stock Titan
Royalty Pharma prices $2B senior unsecured notes - MSN
Royalty Pharma (NASDAQ:RPRX) Reaches New 1-Year HighShould You Buy? - MarketBeat
Royalty Pharma stock hits 52-week high at $50.24 - Investing.com
Teacher Retirement System of Texas Lowers Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma declares $0.235 dividend - MSN
Royalty Pharma in $500M R&D funding collaboration with J&J - MSN
Royalty Pharma plc (RPRX) Stock Analysis: Harnessing Biopharma Royalties with a 6% Upside Potential - DirectorsTalk Interviews
A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum - Yahoo Finance
RPRX.O - Reuters
Zurcher Kantonalbank Zurich Cantonalbank Acquires 219,479 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Best Pharmaceutical Stocks to Buy for April 2026 - Zacks Investment Research
Royalty Pharma PLC $RPRX Shares Purchased by Torray Investment Partners LLC - MarketBeat
Precision Trading with Royalty Pharma Plc (RPRX) Risk Zones - Stock Traders Daily
3 Unpopular Stocks We’re Skeptical Of - Yahoo Finance
Ruffer LLP Has $3.50 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma shares edge higher on acquisition of oncology drug royalties - MSN
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation - The Manila Times
A new $1 million prize will honor scientists who turn discoveries into drugs - Stock Titan
Royalty Pharma PLC (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
UBS raises Royalty Pharma stock price target on biopharma catalysts By Investing.com - Investing.com UK
Royalty Pharma (RPRX) PT Raised to $57 at UBS - StreetInsider
Royalty Pharma Approves Dividend and Expands J&J Research Funding - HarianBasis.co
Is It Too Late To Consider Royalty Pharma (RPRX) After Strong 57% One Year Rally? - Sahm
Royalty Pharma Plc Hits New 52-Week High of USD 50.00 - Markets Mojo
Royalty Pharma Plc (RPRX): Investor Outlook With A Promising 3.56% Potential Upside - DirectorsTalk Interviews
Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now - Yahoo Finance
Moran Wealth Management LLC Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
KBC Group NV Trims Holdings in Royalty Pharma PLC $RPRX - MarketBeat
5 Most Undervalued Biotech Stocks to Buy Right Now - Insider Monkey
Royalty Pharma stock hits 52-week high at $49.07 By Investing.com - Investing.com India
Royalty Pharma declares $0.235 quarterly dividend By Investing.com - Investing.com India
Royalty Pharma PLC (NASDAQ:RPRX) Declares $0.24 Quarterly Dividend - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighShould You Buy? - MarketBeat
Royalty Pharma stock hits 52-week high at $49.07 - Investing.com
2.45%
자본화:
|
볼륨(24시간):